Bills · S 5059
IN COMMITTEE· 119TH CONGRESS
Senate BillS 5059Health
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
INTRO JUL 21· LAST ACTION JUL 21
READING
1MIN
COSPONSORS
3BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
SPONSORSHIP
1 + 3
R· Florida
YRS IN OFFICE
1
BILLS LED
55
COSPONSOR BREAKDOWNBIPARTISAN · 66%
DEM 2 REP 1 IND 0
ACTION TIMELINE
2 EVENTSJUL 21
Introduced in Senate
JUL 21
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 5059
Congress119th
StatusIn Committee
IntroducedJul 21, 2026
Last actionJul 21, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED JUL 21, 2026
Senate BillS 5059Health
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
INTRODUCED JUL 21, 2026· LAST ACTION JUL 21, 2026
PASSAGE CHANCES
—%
READING
1 min
COSPONSORS
3
COMPLEXITY
Moderate
